FibroBiologics FBLG
NASDAQ FBLG
$1.70 -0.06 (-3.43%)
As of: Sep 10, 2026 · 2:02 PM EDT

FibroBiologics (FBLG) Preferred Shares (2022)

FibroBiologics' (FBLG) quarterly Preferred Shares came in at $2.5 million in Q4 2022.

Analysis

FibroBiologics (FBLG) Preferred Shares (2022) Analysis & Trends

FibroBiologics (FBLG) has reported Preferred Shares for 1 consecutive years, with $2.5 million the latest figure, recorded in Q4 2022.

  • For the quarter ending Q4 2022, Preferred Shares changed N/A year-over-year to $2.5 million; the trailing twelve-month figure through Dec 2022 stood at $2.5 million (changed N/A YoY), and the FY2022 full-year result was $2.5 million, changed N/A from the prior year.
  • Preferred Shares was little changed at $2.5 million in Q4 2022 per FBLG's latest filing.
  • Across five years, Preferred Shares topped out at $2.5 million in Q4 2022 and bottomed at $2.5 million in Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Krystal Biotech 10.21 Bn 9.36 Bn 112.79 Mn -
2 CRISPR Therapeutics AG 5.03 Bn 5.03 Bn - -
3 Iovance Biotherapeutics 3.64 Bn 3.34 Bn 55.72 Mn 2,000.00
4 Legend Biotech 3.54 Bn 2.57 Bn 251.50 Mn -
5 uniQure 2.98 Bn 2.98 Bn 5.49 Mn -
6 Beam Therapeutics 2.52 Bn 2.52 Bn - -
7 Precigen 2.38 Bn 2.38 Bn 52.17 Mn -
8 Sarepta Therapeutics 2.14 Bn 1.35 Bn 251.87 Mn -
9 Vericel 1.93 Bn 1.76 Bn 56.40 Mn -
10 FibroBiologics 10.66 Mn 10.66 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 2.50 Mn